Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 300

1.

Pancreatic incidentalomas: high rate of potentially malignant tumors.

Lahat G, Ben Haim M, Nachmany I, Sever R, Blachar A, Nakache R, Klausner JM.

J Am Coll Surg. 2009 Sep;209(3):313-9. doi: 10.1016/j.jamcollsurg.2009.05.009.

PMID:
19717035
2.

Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis.

Winter JM, Cameron JL, Lillemoe KD, Campbell KA, Chang D, Riall TS, Coleman J, Sauter PK, Canto M, Hruban RH, Schulick RD, Choti MA, Yeo CJ.

Ann Surg. 2006 May;243(5):673-80; discussion 680-3.

3.

Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report.

Lee CJ, Scheiman J, Anderson MA, Hines OJ, Reber HA, Farrell J, Kochman ML, Foley PJ, Drebin J, Oh YS, Ginsberg G, Ahmad N, Merchant NB, Isbell J, Parikh AA, Stokes JB, Bauer T, Adams RB, Simeone DM.

J Gastrointest Surg. 2008 Feb;12(2):234-42.

PMID:
18040749
4.

Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible?

Ahrendt SA, Komorowski RA, Demeure MJ, Wilson SD, Pitt HA.

J Gastrointest Surg. 2002 Jan-Feb;6(1):66-74.

PMID:
11986020
5.

Curative laparoscopic resection for pancreatic neoplasms: a critical analysis from a single institution.

Fernández-Cruz L, Cosa R, Blanco L, Levi S, López-Boado MA, Navarro S.

J Gastrointest Surg. 2007 Dec;11(12):1607-21; discussion 1621-2.

PMID:
17896167
6.

The incidental asymptomatic pancreatic lesion: nuisance or threat?

Sachs T, Pratt WB, Callery MP, Vollmer CM Jr.

J Gastrointest Surg. 2009 Mar;13(3):405-15. doi: 10.1007/s11605-008-0788-0.

PMID:
19130153
7.

Cystic pancreatic tumors (CPT): predictors of malignant behavior.

Javle M, Shah P, Yu J, Bhagat V, Litwin A, Iyer R, Gibbs J.

J Surg Oncol. 2007 Mar 1;95(3):221-8.

PMID:
17323335
8.

Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years.

Goh BK, Tan YM, Cheow PC, Chung YF, Chow PK, Wong WK, Ooi LL.

Am J Surg. 2006 Aug;192(2):148-54.

PMID:
16860621
9.

Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.

Goh BK, Tan YM, Chung YF, Cheow PC, Ong HS, Chan WH, Chow PK, Soo KC, Wong WK, Ooi LL.

Arch Surg. 2008 Oct;143(10):956-65. doi: 10.1001/archsurg.143.10.956.

PMID:
18936374
10.

[Surgical effect of malignant tumor of body and tail of the pancreas: compare with pancreatic head cancer].

Wu TC, Shao YF, Shan Y, Wu JX, Zhao P.

Zhonghua Wai Ke Za Zhi. 2007 Jan 1;45(1):30-3. Chinese.

PMID:
17403286
11.

Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?

Teh SH, Deveney C, Sheppard BC.

Am J Surg. 2007 May;193(5):610-3; discussion 613.

PMID:
17434366
12.

Pancreatic serous oligocystic adenomas: clinicopathologic features and a comparison with serous microcystic adenomas and mucinous cystic neoplasms.

Goh BK, Tan YM, Yap WM, Cheow PC, Chow PK, Chung YF, Wong WK, Ooi LL.

World J Surg. 2006 Aug;30(8):1553-9.

PMID:
16773248
13.

Noninvasive pancreatic cystic neoplasms can be safely and effectively treated by limited pancreatectomy.

Tien YW, Hu RH, Hung JS, Wang HP, Lee PH.

Ann Surg Oncol. 2008 Jan;15(1):193-8.

PMID:
17909909
14.

Distal pancreatectomy combined with celiac axis resection in treatment of carcinoma of the body/tail of the pancreas: a single-center experience.

Wu X, Tao R, Lei R, Han B, Cheng D, Shen B, Peng C.

Ann Surg Oncol. 2010 May;17(5):1359-66. doi: 10.1245/s10434-009-0840-7.

PMID:
20198445
15.

Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.

Reddy S, Wolfgang CL, Cameron JL, Eckhauser F, Choti MA, Schulick RD, Edil BH, Pawlik TM.

Ann Surg. 2009 Aug;250(2):282-7. doi: 10.1097/SLA.0b013e3181ae9f93.

PMID:
19638918
16.

Surgical treatment of pancreatic adenocarcinoma: Taiwan experience.

Jan YY, Chen MF, Wang CS, Jeng LB, Hwang TL, Chen SC.

Int Surg. 1996 Jan-Mar;81(1):52-6.

PMID:
8803707
17.

Non ductal-adenocarcinoma neoplasms of the pancreas.

Serio G, Bortolasi L, Iacono C, Montresor E.

Chir Ital. 1999 May-Jun;51(3):181-8.

PMID:
10793762
18.

Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center.

Michalski CW, Kleeff J, Bachmann J, Alkhatib J, Erkan M, Esposito I, Hinz U, Friess H, Büchler MW.

Ann Surg Oncol. 2008 Jan;15(1):186-92.

19.

Is there still a role for total pancreatectomy?

Müller MW, Friess H, Kleeff J, Dahmen R, Wagner M, Hinz U, Breisch-Girbig D, Ceyhan GO, Büchler MW.

Ann Surg. 2007 Dec;246(6):966-74; discussion 974-5.

PMID:
18043098
20.

[Cystic tumors of the pancreas-radical or organ-preserving resection?].

Siech M, Thumerer SU, Henne-Bruns D, Beger HG.

Chirurg. 2004 Jun;75(6):615-21. German.

PMID:
15103421
Items per page

Supplemental Content

Support Center